Details of the Drug

General Information of Drug (ID: DM9FZYT)

• Drug Name: Spesolimab
• Synonyms: BI-655130

Indication

Disease Entry	ICD 11	Status	REF
Psoriasis vulgaris	EA90	Approved	[1]
Palmoplantar pustulosis	EA90.42	Phase 2	[2]
Plaque psoriasis	EA90.0	Phase 2	[2]

• Cross-matching ID: TTD ID: D0W9YW

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
IL-1 receptor-like 2 (IL1RL2)	TTUS18T	ILRL2_HUMAN	Antagonist	[2]

References

• [1] FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761244.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)